PRTN3 and rheumatoid arthritis: CCR6 is a marker of Th17 cells, in agreement with the aforementioned study, increased frequency of IFN-γ producing Th1 and IL-17A producing Th17 cells in the periphery of ACPA+ compared to ACPA− RA patients has been reported [10].